Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02395003 · ClinicalTrials.gov registry record
Study to Investigate Adipocyte Cell and Lipid Turnover in Obese Adolescents
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 26
- Enrollment target
NCT02395003: Completed study, sponsored by Yale University.
NCT02395003 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02395003 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
Insulin Resistance is the best predictor of whether the obese adolescent will develop type 2 diabetes. The present studies will focus on determining what might cause fat to accumulate in the subcutaneous fat regions and lead to local inflammation, causing insulin resistance to develop in obese adolescents.
Primary Outcome
1\) To test whether the reduced transcription of key lipogenic/adipogenic genes in abd SAT in obese adolescents with a High VAT/SAT ratio translates functionally into a reduced in vivo TG synthesis and adipocyte proliferation, which in turn will contribute to ectopic fat accumulation and IR.
Interventions
- OTHER Palmitate Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2016-04 |
| Est. Completion | 2023-03-07 |
What the finished NCT02395003 record still lists
NCT02395003 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Palmitate Diet is the first listed.
NCT02395003 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02395003 about?
NCT02395003 is a clinical study titled "Study to Investigate Adipocyte Cell and Lipid Turnover in Obese Adolescents". Insulin Resistance is the best predictor of whether the obese adolescent will develop type 2 diabetes. The present studies will focus on determining what might cause fat to accumulate in the subcutaneous fat regions and lead to local inflammation, causing insulin resistance to develop in obese adole...
What is the current status of trial NCT02395003?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2016-04. Estimated completion is 2023-03-07.
What interventions are being tested in trial NCT02395003?
The interventions under investigation include: Palmitate Diet (OTHER).
Who is sponsoring clinical trial NCT02395003?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia